Craneware Regulatory News (CRW)

Craneware plc("Craneware" or the "Company")

 Bank Refinancing

1 September 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, is pleased to announce the successful refinancing of its banking facilities, providing increased flexibility to execute its growth strategy, alongside the Group's ongoing strong cash generation and proposed increase to distributable reserves.

The Group has renewed its Revolving Credit Facility ("RCF") on improved terms, for a further three years, with the option to extend for two further one-year terms. This new unsecured $100m RCF consolidates the previous term loan and RCF, is at lower interest rates than the previous facilities, and provides a further $100m accordion facility that could support potential M&A activities. The facilities have been provided by a consortium of HSBC, Barclays, NatWest and Santander.

Alongside the Refinancing, the Board has initiated a proposed reduction of capital, as announced on 1 August 2025. This would create additional distributable reserves of $284.2m, if ultimately approved by the Court process, giving the Company further flexibility to deliver shareholder returns over the coming years, either in the form of distributions and/or purchases of the Company's own shares. Following the approval of the resolutions to approve the proposed capital reduction on 20 August 2025, the first court hearing for initial direction is expected to be held shortly.

In July 2025, the Group confirmed it had experienced positive trading throughout the fiscal year ended 30 June 2025, delivering continued strong revenue growth, and a double digit increase to profitability, ahead of prior expectations. The Group continued to deliver high levels of operating cash conversion, which have been invested in the product portfolio, and reducing debt, with total bank debt reduced to $27.7m at 30 June 2025 (FY24: $35.4m), whilst retaining healthy total cash reserves of $55.9m (FY24: $34.6m).

The Group will announce audited Final Results for the year ended 30 June 2025 on 15 September 2025.

Keith Neilson, CEO of Craneware plc commented, "We would like to thank our banking partners for their continued support of the business and belief in our growth strategy. Our strategic position at the heart of the U.S. healthcare market, strong balance sheet and positive trading provides us with a strong position from which to explore multiple avenues for growth, as we support our customers in the transformation of the business of healthcare."

For further information, please contact:

About The Craneware Group

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth.

As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster-that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider.

The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve-today and in the future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com